Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2008-03-04
2008-03-04
Qian, Celine (Department: 1636)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C424S493000, C424S461000, C530S300000
Reexamination Certificate
active
07338931
ABSTRACT:
The present invention relates to a new hydrophobe biomolecular structure, which is compacted due to the passing of the structure over its point of collapse, a method for the preparation of the structure and use of the new structure for the manufacture of a medicament.
REFERENCES:
patent: 4141973 (1979-02-01), Balazs
patent: 5614212 (1997-03-01), D'Angelo et al.
patent: 5637566 (1997-06-01), Walker et al.
patent: 5654006 (1997-08-01), Fernandez et al.
patent: 5844107 (1998-12-01), Hanson et al.
patent: 6087171 (2000-07-01), Neuman et al.
patent: 014995 (1980-03-01), None
patent: 014996 (1980-09-01), None
patent: 138572 (1985-04-01), None
patent: 0 522 491 (1993-01-01), None
patent: 10158196 (1998-06-01), None
patent: WO9005522 (1990-05-01), None
patent: WO 9629998 (1996-10-01), None
patent: WO 97/15330 (1997-05-01), None
patent: WO9715330 (1997-05-01), None
patent: WO 9715330 (1997-05-01), None
patent: WO 9843664 (1998-10-01), None
patent: WO 01/36656 (2001-05-01), None
Cravioto et al. Effects of precipitates formed by insulin with hyaluronic acid and mucoid from vitreous humor in depressing blood sugar levels. Science, vol. 111, No. 2889, pp. 520-521, May 12, 1950.
Illuma et al. Hyaluronic acid ester microspheres as a nasal delivery system for insulin. Journal of Controlled Release, vol. 29, Issues 1-2, pp. 133-141, Feb. 1994.
Jederstrom et al. Formulating insulin for oral administration: preparation of hyaluronan-insulin complex. Pharmaceutical Research, vol. 21, No. 11, pp. 2040-2047, Nov. 2004.
Jederstrom et al. Bood glucose-lowering activity of a hyaluronan-insulin complex after oral administration to rats with diabetes. Diabetes Technology & Therapeutics, vol. 7, No. 6, 2005.
Verma et al. Gene therapy—promises, problems and prospects. Nature. vol. 389, No. 6648, pp. 239-242, Sep. 1997.
Palu et al. In pursuit of new developments for gene therapy of human diseases. J Biotechnol. vol. 68, No. 1, pp. 1-13, Feb. 1999.
Luo et al. Synthetic DNA delivery systems. Nat Biotechnol. vol. 18, No. 1, pp. 33-37, Jan. 2000.
Edelstein et al. Gene therapy clinical trials worldwide 1989-2004-an overview. J Gene Med. vol. 6, No. 6, pp. 597-602, Jun. 2004.
Diabetes entry in Dorland's Illustrated Medical Dictionary, available online at http://www.mercksource.com/pp/us/cns/cns—hl—dorlands.jsp?pg=/pp/us/common/dorlands/dmd—a-b—00.htm, printed on Sep. 12, 2006.
Dunston Jennifer
Qian Celine
Young & Thompson
LandOfFree
Hydrophobic biomolecular structure does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Hydrophobic biomolecular structure, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hydrophobic biomolecular structure will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2806045